-       Report 
- October 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  354 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  190 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
           -       Report 
- March 2025
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- August 2025
-  189 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  190 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  494 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- March 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- December 2024
-  586 Pages 
- Global 
   From       €2679EUR$2,995USD£2,356GBP 
          -       Report 
- December 2024
-  403 Pages 
- Global 
   From       €1337EUR$1,495USD£1,176GBP 
          -       Report 
- April 2025
-  200 Pages 
- United States 
   From       €2227EUR$2,490USD£1,959GBP 
            -       Report 
- June 2025
-  119 Pages 
- United States 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- July 2025
-  250 Pages 
- Middle East, Africa 
   From       €3461EUR$3,869USD£3,044GBP 
          -       Report 
- May 2023
-  155 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- December 2022
-  105 Pages 
- Europe 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- August 2025
-  118 Pages 
- Japan 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
       
      Branded generics are generic drugs that are marketed under a brand name. They are typically manufactured by a generic drug company, but are sold under a brand name owned by a pharmaceutical company. Branded generics are typically sold at a higher price than generic drugs, but are still much cheaper than the original brand-name drug. They are often used to increase the market share of a generic drug company, as well as to increase the visibility of a generic drug in the marketplace.
Branded generics    are becoming increasingly popular in the pharmaceutical industry, as they offer a cost-effective alternative to brand-name drugs. They are also used to increase the market share of generic drug companies, as well as to increase the visibility of generic drugs in the marketplace.
Some companies in the branded generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less   Read more